SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-006734
Filing Date
2022-01-11
Accepted
2022-01-11 16:05:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d151200dsc13g.htm SC 13G 36221
  Complete submission text file 0001193125-22-006734.txt   37647
Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93228 | Film No.: 22523936
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 513.579.9911
CinRx Pharma, LLC (Filed by) CIK: 0001903629 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: SC 13G